If you can't read please download the document
Upload
teenie
View
126
Download
3
Tags:
Embed Size (px)
DESCRIPTION
Burkholderia cepacia. Helgi Karl Engilbertsson 25. febrúar 2004. Burkholderia cepacia sýkingar. Sepsis Pneumonia Meningitis Cellulitis Peritonitis Endocarditis Pericarditis Cholangitis Septic arthritis Urinary tract infections. Medically Important Pseudomonads. - PowerPoint PPT Presentation
Citation preview
Burkholderia cepaciaHelgi Karl Engilbertsson25. febrar 2004
Burkholderia cepacia skingarSepsisPneumoniaMeningitisCellulitisPeritonitisEndocarditisPericarditisCholangitisSeptic arthritisUrinary tract infections
Medically Important PseudomonadsrRNA homology group I-VGr. I Pseudomonas, 6 tegGr. IIa Burkholderia, a.m.k. 22 tegGr. IIb Ralstonia, 4 tegGr. IIc Oxalobacter, 1 tegGr. IId Pandorae, 4 tegGr. III Comamonas, 2 tegGr. IV Brevundimonas, 2 tegGr. V Stenotrophomonas, 2 teg
MicrobiologyGram-negatfur stafurExtracellulerAerobicNon-fermentiveCatalaseFlagella2-4 circular replicons sta circular chromosomesErfitt a einangraRktun srhfu media
Burkholderia cepacia
Burkholderia cepaciaPseudomonas cepacia var lst fyrst ri 1950 af Walter Burkholder (Cornell University plant pathologist ), sem plntupathogen. Veldur rotnun lauk (latna, cepia)Siar kemur ljs a tkfris human pathogenarnir P. Kingii og P. Multivarans voru smu tegundar.Sustu 10 r komi ljs vi taxonmskar rannsknir stofn baktera, Burkholder cepacia complex
Burkholder cepacia complexMismunandi genotypur me mjg svipaar phenotypurGenomovar I-IXB. cepaciaB. multivoransB. cenocepaciaB. StabilisB. VietnamiensisB. DolosaB. AmbifariaB. AnthinaB. pyrrocinia
Burkholder cepaciaFinnst va:VatniJarvegiDrumMnnumSptalaumhverfiKranavatnInnavlarDialysuvlarStthreinsivkvaIV lausnirCatheterarOg fleira
Burkholderia cepacia skingarTkifrisskillAlgengast hj sjklingum me undirliggjandi sjkdmaCystic fibrosis3,5 % CF sjklinga USA20-30% skinga enda me bacteremiu og dauaChronic granulomatous diseasenmisbldumDMMalignancyHjartabilunCOPD
Burkholderia cepacia pathogenesisVirulence faktorarLyfjanmiAdherance vi plastExoenzymeElastasiGelatinasiAdhesinResistance to nonoxative killing of neutrophilsIntracellular survivalSiderophoresHemolysinExopolysaccharidePiliFlagella
Burkholderia cepacia pathogenesisFinnast helst ndunarvegiColonisering frekar en sking yfirleittSking getur leitt tilNecrotizing pneumoniaBacteremiuEcthyma gangrenosumDICSeptsks shockMultible organ dysfunction syndrome
Ecthyma gangrenosum
Burkholderia cepacia lyfjanmiBeta-laktamasiPenicilln resistanceDihydrofolate reductasiTrimethoprim resistanceAntibiotic efflux pumpChloramphenicol, quinolone og trimethoprim resistanceYtri himnu gegndrpiQuinolone resistanceBreyting bindista lyfja
Burkholderia cepacia meferCystic FibrosisMinocycline 33% nmiMeropenem 28%Chloramphenicol/Minocycline 49%Chloramphenicol/Ceftazidime 26%
Burkholderia cepacia meferBacteremiaCeftazidime (95%)Piperacillin (93%)Minocycline (85%)Cefotaxime (82%)CiprofloxacinImipenemMeropenemQuinolonesTrimethoprimChloramphenicol
MIC = Minimum inhibitory concentrationMIC breakpoints for resistance: Piperacillin 128 g/ml, Ceftazidime 32 g/ml, imipenem 16 g/ml, gentamicin 16 g/ml, minocycline 16 g/ml, Ciprofloxacin 4 g/ml
AntibioticMIC (g/ml)50%MIC (g/ml)90%Resistant isolates (%)Piperacillin8646.1Ceftazidime483.0Imipenem41621.2Gentamicin64>128100Minocycline486.1Ciprofloxacin123.0
Capsule: 90 teg. Antiphagocytic.Adherence: Prtein sem tengjast samgildum tengjum vi prteingrind bakteruveggsins. Tengist gegnum essi prtein sykrungum frumuhimnu hsilsins, ea vitaka platelet activating factor.